ALDH1A2 and amyotrophic lateral sclerosis: Furthermore, the mutation-induced reductions in ALDH1A2 mRNA and protein levels were significantly reduced by APG (Fig. 5I, J), confirming the hypothesis from in vivo experiments that ALDH1A2 plays a role in the protective mechanisms of APG in ALS models.